Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (29)
- Medical Toxicology (12)
- Diseases (11)
- Life Sciences (9)
- Chemicals and Drugs (8)
-
- Medical Education (8)
- Pharmacy and Pharmaceutical Sciences (8)
- Mental and Social Health (7)
- Pharmaceutical Preparations (7)
- Public Health (7)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (6)
- Chemical and Pharmacologic Phenomena (6)
- Oncology (6)
- Pharmacology, Toxicology and Environmental Health (6)
- Neurosciences (5)
- Cardiology (4)
- Endocrinology, Diabetes, and Metabolism (4)
- Infectious Disease (4)
- Medical Immunology (4)
- Medical Physiology (4)
- Obstetrics and Gynecology (4)
- Physiology (4)
- Substance Abuse and Addiction (4)
- Behavioral Medicine (3)
- Community Health (3)
- Family Medicine (3)
- Medical Microbiology (3)
- Institution
-
- University of Kentucky (10)
- Thomas Jefferson University (6)
- Wayne State University (5)
- LSU Health New Orleans (4)
- University of Louisville (4)
-
- Arcadia University (3)
- University of Nebraska Medical Center (3)
- Valparaiso University (3)
- Wright State University (3)
- HCA Healthcare (2)
- Marshall University (2)
- Munster Technological University (2)
- Sacred Heart University (2)
- United Arab Emirates University (2)
- University of Connecticut (2)
- Abilene Christian University (1)
- Bridgeport Hospital (1)
- Children's Mercy Kansas City (1)
- Himmelfarb Health Sciences Library, The George Washington University (1)
- Loma Linda University (1)
- Rowan University (1)
- The British University in Egypt (1)
- University of Mississippi (1)
- University of Nebraska - Lincoln (1)
- University of Nevada, Las Vegas (1)
- University of Rhode Island (1)
- University of Tennessee Health Science Center (1)
- University of Texas Rio Grande Valley (1)
- Virginia Commonwealth University (1)
- Keyword
-
- COVID-19 (4)
- Inflammation (3)
- Over-the-counter (3)
- SARS-CoV-2 (3)
- Aspirin (2)
-
- Cancer (2)
- Cardiotoxicity (2)
- Critical care (2)
- Diabetes (2)
- Ibuprofen (2)
- Immunotherapy (2)
- Insulin resistance (2)
- Non-small cell lung cancer (2)
- Obesity (2)
- Oxidative stress (2)
- Painkillers (2)
- Paracetamol (2)
- Pharmacology (2)
- Risks (2)
- 17-hydroxyprogesterone caproate (1)
- 3D Printing (1)
- 3rd level students (1)
- 5-Fluorouracil (1)
- <p>Diabetes -- Complications -- Research.</p> <p>Wounds and injuries -- Treatment -- Research.</p> <p>Pharmacy<strong> -- </strong>Research.</p> (1)
- AHUS (1)
- AKI (1)
- AKT (1)
- APP/PS1 transgenic mice (1)
- Abortion (1)
- Acetaminophen (1)
- Publication
-
- Pharmacology and Nutritional Sciences Faculty Publications (8)
- Clinical Research in Practice: The Journal of Team Hippocrates (5)
- Department of Pharmacology and Experimental Therapeutics Faculty Papers (4)
- Electronic Theses and Dissertations (4)
- Capstone Showcase (3)
-
- Journal of Mind and Medical Sciences (3)
- Medical Student Research Symposium Abstracts and Posters (3)
- School of Medicine Faculty Publications (3)
- HCA Healthcare Journal of Medicine (2)
- International Undergraduate Journal of Health Sciences (2)
- Journal Articles: Pharmacology & Experimental Neuroscience (2)
- Physician Associate Studies Faculty Publications (2)
- Dissertations (1)
- Graduate Research Posters (1)
- Holster Scholar Projects (1)
- Honors Scholar Theses (1)
- Honors Theses (1)
- Institute of Emerging Health Professions Faculty Papers (1)
- Kimmel Cancer Center Faculty Papers (1)
- Loma Linda University Electronic Theses, Dissertations & Projects (1)
- MEDI 9331 Scholarly Activities Clinical Years (1)
- Pharmaceutical Science and Research (1)
- Pharmacology and Nutritional Sciences Textbook Gallery (1)
- Pharmacology and Physiology Faculty Publications (1)
- Pharmacy (1)
- Physiology Faculty Publications (1)
- Posters (1)
- Research Days (1)
- Rowan-Virtua Research Day (1)
- School of Graduate Studies Faculty Publications (1)
- Publication Type
- File Type
Articles 61 - 67 of 67
Full-Text Articles in Medical Pharmacology
Precision Nutrition And Advanced Culinary Medicine, Sara B. Police
Precision Nutrition And Advanced Culinary Medicine, Sara B. Police
Pharmacology and Nutritional Sciences Textbook Gallery
This electronic textbook (eBook) accompanies NS801, Precision Nutrition and Advanced Culinary Medicine, a 1-credit, 8-week online medical elective course for the University of Kentucky College of Medicine Office of Medical Education. The eBook provides module-based background information including text, tables, and figures to support each module of the online course:
- Introduction
- Culinary Challenges Preparation
- Emerging Concepts in Precision Nutrition
- Cardiovascular Disease & Nutritional Considerations
- Neurological and Mental Health Disorders & Nutritional Considerations
- Cancer & Nutritional Considerations
- Gastrointestinal (GI) Health, Microbiome & Nutritional Considerations
- Renal Conditions & Nutritional Considerations
As an open access textbook supported by the University of Kentucky Libraries …
Efficacy And Safety Of Once-Daily Vibegron For Treatment Of Overactive Bladder In Patients Aged ≥65 And ≥75 Years: Subpopulation Analysis From The Empowur Randomized, International, Phase Iii Study, Susann Varano, David Staskin, Jeffrey Frankel, Denise Shortino, Rachel Jankowich, Paul N. Mudd
Efficacy And Safety Of Once-Daily Vibegron For Treatment Of Overactive Bladder In Patients Aged ≥65 And ≥75 Years: Subpopulation Analysis From The Empowur Randomized, International, Phase Iii Study, Susann Varano, David Staskin, Jeffrey Frankel, Denise Shortino, Rachel Jankowich, Paul N. Mudd
Physician Associate Studies Faculty Publications
Background
Overactive bladder (OAB) is common among older adults. The efficacy and safety of vibegron for the treatment of OAB were demonstrated in the international, phase III EMPOWUR trial. This subpopulation analysis from EMPOWUR assessed the efficacy and safety of vibegron in patients aged ≥ 65 and ≥ 75 years.
Methods
In EMPOWUR, patients with OAB were randomly assigned 5:5:4 to receive once-daily vibegron 75 mg, placebo, or tolterodine 4 mg extended release, respectively, once daily for 12 weeks. Coprimary efficacy endpoints were change from baseline at week 12 in average daily number of micturitions and urge urinary incontinence (UUI) …
Opioid Use Disorder: The Timeline For Medication Assisted Therapy, Alexander Cristofori
Opioid Use Disorder: The Timeline For Medication Assisted Therapy, Alexander Cristofori
Capstone Showcase
Opioid Use Disorder is patterns of opioid use leading to withdrawal, giving up important life events in order to use opioids, and excessive time spent using opioids, to name a few diagnostic criteria. The clinical progression of the disorder involves periods of acute exacerbation and remission that are cyclic in nature. Treatment is most effective when it includes both pharmacological and psychosocial modalities, referred to as medication assisted therapy (MAT). Three drugs used commonly in MAT-based treatment for OUD from oldest to newest include Methadone, Buprenorphine-naloxone, and Naltrexone. Treatment program models that prioritize total abstinence from the addictive substance attached …
Efficacy Of Pcsk9 Inhibitors Compared To Standard Of Care In Improving The Low-Density-Lipoprotein Cholesterol And Lowering The Risk Of Cardiovascular Events In Patients With Familial Hypercholesterolemia, Nichole Warshany
Capstone Showcase
Familial hypercholesterolemia is an inherited condition that causes patients to have significantly increased levels of LDL cholesterol, which often leads to coronary artery disease. Statin medications are typically prescribed to treat this condition, however these medications have adverse side effects and often subpar efficacy in this patient population. Evidence collected in this literature review yielded evidence that the use of PCSK9 inhibitors in the treatment of patients with familial hypercholesterolemia may be efficacious. Many of these studies were able to show statistically significant improvement of LDL-C and decrease in cardiovascular risk when compared to placebo. In addition, this medication was …
The Efficacy Of In Vitro Fertilization In Treating Infertility Due To Anovulatory Pcos In Comparison To Ovulation Induction Via Letrozole, Amanda Salay
Capstone Showcase
Abstract:
Introduction: Polycystic Ovarian Syndrome (PCOS) is an endocrine disorder found in women of reproductive age that often causes infertility. The first-line treatment for infertility in anovulatory PCOS patients is ovulation induction. In vitro fertilization (IVF) is a third line treatment often used as a last resort. PCOS patients have higher failure risks of first- and second-line medications. Therefore, this review analyzes if adverse pregnancy outcomes (O) are reduced more with IVF (I) versus using letrozole for ovulation induction (C) in women aged 20-30 struggling with infertility due to anovulatory PCOS (P).
Methods: A literature search on Pubmed and EBSCOhost …
Potential Perioperative Complications Due To Difference In Timing Of Systemic Heparinization During Ruptured Aneurysm Coiling, Rouzbeh Kotaki, Ameer E. Hassan, Wondwossen G. Tekle
Potential Perioperative Complications Due To Difference In Timing Of Systemic Heparinization During Ruptured Aneurysm Coiling, Rouzbeh Kotaki, Ameer E. Hassan, Wondwossen G. Tekle
MEDI 9331 Scholarly Activities Clinical Years
Potential Perioperative Complications Due To Differences in Timing Of Systemic Heparin Distribution During Ruptured Aneurysm Coiling
Introduction:
In general, systematic heparin anticoagulation is standard in regards to neurovascular intervention. When coiling ruptured aneurysms, many neurointerventionalists have their own protocol as to timing of systemic heparinization. There is ample research and literature reviewing the frequency of perioperative events, predictors and outcomes, as well as the efficacy in the use of anticoagulants and/or antiplatelets before, during, and after neurovascular procedures to prevent adverse outcomes. However, there currently exists a dearth of research in regards to timing of distribution of heparin intraoperatively and …
Selective Gsk3b Deletion In Camk2a+ Forebrain Neurons Or Inhibition Via Tideglusib, Decreases Ethanol Consumption In C57bl/6j Mice, Sam Gottlieb, Andrew D. Van Der Vaart, Brennen O'Rourke, Michael F. Miles
Selective Gsk3b Deletion In Camk2a+ Forebrain Neurons Or Inhibition Via Tideglusib, Decreases Ethanol Consumption In C57bl/6j Mice, Sam Gottlieb, Andrew D. Van Der Vaart, Brennen O'Rourke, Michael F. Miles
Graduate Research Posters
Purpose: We previously identified glycogen synthase kinase-3 beta (Gsk3b) as a central member of a gene network highly regulated by acute ethanol in medial prefrontal cortex (mPFC) and associated with risk for alcohol dependence in humans. Further, we have demonstrated modulation of Gsk3b alters ethanol consumption in rodent models. GSK3B could thus represent a potential new therapeutic target for the treatment of alcohol use disorder (AUD). Here, we investigate the mechanisms of Gsk3b action in ethanol consumption and report preclinical evidence for the selective GSK3B inhibitor, tideglusib, as a therapeutic agent for AUD.
Methods: (1) Selective Cre-induced Gsk3b …